{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:42:02Z","timestamp":1794886922033,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007691","name":"Universidade da Beira Interior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009362","name":"South London and Maudsley NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King&apos;s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.psyneuen.2026.107915","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:59:38Z","timestamp":1781200778000},"page":"107915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Intranasal oxytocin for alcohol use disorder: A systematic review and multilevel, bayesian, and variance meta-analyses of randomized clinical trial data"],"prefix":"10.1016","volume":"191","author":[{"given":"V\u00edtor Hugo","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannis","family":"Paloyelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Ramos","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Tjeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Carri\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3391-0647","authenticated-orcid":false,"given":"Lia","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.psyneuen.2026.107915_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00406-020-01115-0","article-title":"Oxytocin attenuates neural response to emotional faces in social drinkers: an fMRI study","volume":"271","author":"Bach","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2026.107915_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104385","article-title":"Oxytocin modulates alcohol-cue induced functional connectivity in the nucleus accumbens of social drinkers","volume":"109","author":"Bach","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/j.psyneuen.2026.107915_bib3","first-page":"301","article-title":"Social effects of oxytocin in humans: context and person matter","volume":"15","author":"Bartz","year":"2011","journal-title":"Trends Cogn. Sci."},{"issue":"1","key":"10.1016\/j.psyneuen.2026.107915_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jrsm.1594","article-title":"Robust Bayesian meta\u2010analysis: Model\u2010averaging across complementary publication bias adjustment methods","volume":"14","author":"Barto\u0161","year":"2023","journal-title":"Res. Synth. Methods"},{"issue":"12","key":"10.1016\/j.psyneuen.2026.107915_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2017.10.003","article-title":"Rebalancing the addicted brain: oxytocin interference with the neural substrates of addiction","volume":"40","author":"Bowen","year":"2017","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.psyneuen.2026.107915_bib6","first-page":"115","article-title":"Correcting for bias in psychology: a comparison of meta-analytic methods","volume":"2","author":"Carter","year":"2019","journal-title":"Adv. Methods Pract. Psychol. Sci."},{"issue":"2","key":"10.1016\/j.psyneuen.2026.107915_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.psyneuen.2026.107915_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1037\/pha0000232","article-title":"Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder","volume":"27","author":"Flanagan","year":"2019","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2026.107915_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpsychires.2022.06.011","article-title":"A randomized controlled trial examining the effects of intranasal oxytocin on alcohol craving and intimate partner aggression among couples","volume":"152","author":"Flanagan","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"10152","key":"10.1016\/j.psyneuen.2026.107915_bib10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","author":"GBD 2016 Alcohol Collaborators","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.psyneuen.2026.107915_bib11","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"18","key":"10.1016\/j.psyneuen.2026.107915_bib12","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and metaanalysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.psyneuen.2026.107915_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.biopsych.2015.05.003","article-title":"Intranasal oxytocin: myths and delusions","volume":"79","author":"Leng","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psyneuen.2026.107915_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.psyneuen.2026.107915_bib15","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41467-020-14845-5","article-title":"Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans","volume":"11","author":"Martins","year":"2020","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.psyneuen.2026.107915_bib16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.2023.19761","article-title":"Pharmacotherapy for alcohol use disorder: a systematic review and meta-analysis","volume":"330","author":"McPheeters","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.psyneuen.2026.107915_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.01.003","article-title":"Effect of intranasal oxytocin on alcohol withdrawal syndrome: a randomized placebo-controlled double-blind clinical trial","volume":"197","author":"Melby","year":"2019","journal-title":"Drug. Alcohol. Depend."},{"issue":"5","key":"10.1016\/j.psyneuen.2026.107915_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/alcalc\/agaa133","article-title":"Efficacy of self-administered intranasal oxytocin on alcohol use and craving after detoxification in patients with alcohol dependence: a double-blind placebo-controlled trial","volume":"56","author":"Melby","year":"2021","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.psyneuen.2026.107915_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105185","article-title":"The effectiveness of oxytocin for treating substance use disorders: a systematic review of randomized placebo-controlled trials","volume":"151","author":"Mellentin","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.psyneuen.2026.107915_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/ADM.0000000000000213","article-title":"Intranasal oxytocin selectively modulates social perception, craving, and approach behavior in subjects with alcohol use disorder","volume":"10","author":"Mitchell","year":"2016","journal-title":"J. Addict. Med."},{"issue":"8","key":"10.1016\/j.psyneuen.2026.107915_bib21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1017\/S109285290000047X","article-title":"A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder","volume":"15","author":"Olff","year":"2010","journal-title":"CNS Spectr."},{"issue":"8","key":"10.1016\/j.psyneuen.2026.107915_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biopsych.2014.10.005","article-title":"A spatiotemporal profile of in vivo cerebral blood flow changes following intranasal oxytocin in humans","volume":"79","author":"Paloyelis","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psyneuen.2026.107915_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/add.13974","article-title":"Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta\u2010analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate","volume":"113","author":"Palpacuer","year":"2018","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.psyneuen.2026.107915_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1530-0277.2012.01958.x","article-title":"Intranasal oxytocin blocks alcohol withdrawal in human subjects","volume":"37","author":"Pedersen","year":"2013","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"5","key":"10.1016\/j.psyneuen.2026.107915_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.103","article-title":"Dosedependent social-cognitive effects of intranasal oxytocin delivered with Breath Powered device in adults with autism spectrum disorder: a randomized clinical trial","volume":"7","author":"Quintana","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.psyneuen.2026.107915_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.93","article-title":"Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment","volume":"5","author":"Quintana","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.psyneuen.2026.107915_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/biostatistics\/kxq046","article-title":"Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis","volume":"12","author":"R\u00fccker","year":"2011","journal-title":"Biostatistics"},{"issue":"2","key":"10.1016\/j.psyneuen.2026.107915_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.biopsych.2015.10.014","article-title":"Understanding the oxytocin system and its relevance to psychiatry","volume":"79","author":"Shamay-Tsoory","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.psyneuen.2026.107915_bib29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.biopsych.2017.04.015","article-title":"Kinetics and dose dependency of intranasal oxytocin effects on amygdala reactivity","volume":"82","author":"Spengler","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.psyneuen.2026.107915_bib30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.psyneuen.2026.107915_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.biopsych.2015.06.016","article-title":"Statistical and methodological considerations for the interpretation of intranasal oxytocin studies","volume":"79","author":"Walum","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2026.107915_bib32","series-title":"Global status report on alcohol and health 2018","author":"World Health Organization","year":"2018"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453026001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453026001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:44:02Z","timestamp":1785894242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453026001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S0306453026001757"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2026.107915","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal oxytocin for alcohol use disorder: A systematic review and multilevel, bayesian, and variance meta-analyses of randomized clinical trial data","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2026.107915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107915"}}